# SELLAS Life Sciences to Participate in Upcoming Investor Conferences
Canonical URL: https://biopharmsignal.com/news/SLS/sellas-life-sciences-to-participate-in-upcoming-investor-conferences
Ticker: SLS
Company: SELLAS Life Sciences Group, Inc.
Source: SELLAS Life Sciences Group, Inc.
Published: 2026-05-14 12:00 EST
Original Source URL: https://ir.sellaslifesciences.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-05-14 12:00 EST — [SELLAS Life Sciences to Participate in Upcoming Investor Conferences](https://biopharmsignal.com/news/SLS/sellas-life-sciences-to-participate-in-upcoming-investor-conferences) — Source: SELLAS Life Sciences Group, Inc.
- 2026-05-12 20:05 EST — [SELLAS Life Sciences Reports First Quarter 2026 Financial Results and Provides Corporate Update](https://biopharmsignal.com/news/SLS/sellas-life-sciences-reports-first-quarter-2026-financial-results-and-provides-corporate-update) — Source: SELLAS Life Sciences Group, Inc.
- 2026-03-19 20:05 EST — [SELLAS Life Sciences Reports Full Year 2025 Financial Results and Provides Corporate Update](https://biopharmsignal.com/news/SLS/sellas-life-sciences-reports-full-year-2025-financial-results-and-provides-corporate-update) — Source: SELLAS Life Sciences Group, Inc.
- 2026-03-17 20:30 EST — [SELLAS Life Sciences to Present Preclinical Data Highlighting Potent Activity of SLS009 in AML at the 2026 AACR Conference](https://biopharmsignal.com/news/SLS/sellas-life-sciences-to-present-preclinical-data-highlighting-potent-activity-of-sls009-in-aml-at-the-2026-aacr-conference) — Source: SELLAS Life Sciences Group, Inc.
- 2026-03-12 12:35 EST — [SELLAS Life Sciences Announces Enrollment of First Patient in Newly Diagnosed First-Line AML Trial of SLS009](https://biopharmsignal.com/news/SLS/sellas-life-sciences-announces-enrollment-of-first-patient-in-newly-diagnosed-first-line-aml-trial-of-sls009) — Source: SELLAS Life Sciences Group, Inc.
## Related News
- 2026-07-21 20:15 EST — BFRG — [BullFrog AI to Participate in Water Tower Research Fireside Chat on Thursday, July 23, 2026](https://biopharmsignal.com/news/BFRG/bullfrog-ai-to-participate-in-water-tower-research-fireside-chat-on-thursday-jul-78357ce8)
- 2026-07-21 20:05 EST — CLPT — [ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026](https://biopharmsignal.com/news/CLPT/clearpoint-neuro-to-announce-second-quarter-2026-results-august-3-2026-6e4f3c05)
- 2026-07-21 20:05 EST — TCMD — [Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026](https://biopharmsignal.com/news/TCMD/tactile-medical-to-release-second-quarter-of-fiscal-year-2026-financial-results--798d4004)
- 2026-07-21 20:05 EST — PIII — [P3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference Call](https://biopharmsignal.com/news/PIII/p3-health-partners-schedules-second-quarter-2026-earnings-release-and-conference-6c9bd8a7)
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)